- Home
- RLTY vs SOPH Comparison
RLTY vs SOPH Comparison
Compare RLTY & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLTY | SOPH |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.3M | 330.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | RLTY | SOPH |
|---|---|---|
| Price | $14.50 | $4.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 86.7K | 76.0K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 9.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | N/A | $15.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $11.38 | $2.58 |
| 52 Week High | $14.60 | $5.30 |
Technical Indicators
Market Signals| Indicator | RLTY | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 41.08 | 47.87 |
| Support Level | $14.28 | $4.60 |
| Resistance Level | $14.69 | $4.84 |
| Average True Range (ATR) | 0.18 | 0.23 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 32.93 | 17.51 |
Price Performance
Historical ComparisonAbout RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.